Pfizer: Short-Term Noise or Long-Term Benefits?

Pfizer stands to lose approximately $17B in sales over the next several years due to the loss of exclusivity on several large drug franchises. Find out why we believe this short-term noise may not outweigh the benefits for long-term investors.

Webinar: Ask a PM – Episode 2

Portfolio Managers Eric Schoenstein and Allen Bond answer questions about the most important things FAs can tell their clients right now.

Ask a Portfolio Manager: Episode 2

Portfolio Managers Eric Schoenstein and Allen Bond answer questions about the most important things FAs can tell their clients right now.

2022 Quality Value Fund Annual Webinar

Join Jensen Portfolio Manager Kurt Havnaer for an annual overview of the Jensen Quality Value Fund’s 2022 performance, portfolio activity and future outlook.